Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 with DAC and GHRP-2 Interaction: Synergistic | Peptide Database

Can you take CJC-1295 with DAC with GHRP-2? Synergistic interaction (55% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take CJC-1295 with DAC with GHRP-2?

Yes, CJC-1295 with DAC and GHRP-2 can generally be taken together. CJC-1295 with DAC and GHRP-2 amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone.

Is CJC-1295 with DAC and GHRP-2 safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and GHRP-2?

CJC-1295 with DAC and GHRP-2 amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and GHRP-2?

CJC-1295 with DAC has a half-life of 6-8 days and GHRP-2 has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question